1º PREMIO COQ ASISA-UAH + ACCÉSIT A MEJORES TRABAJOS PUBLICADOS EN EL ÁMBITO SEOQ

ACTIVIDADES 2021

1º PREMIO COQ ASISA-UAH A LOS MEJORES TRABAJOS PUBLICADOS EN REVISTAS DEL ÁMBITO DE LA SEOQ

10 y 11 de Junio de 2021

Los días 10 y 11 de junio se ha celebrado el WORKSHOP (virtual) SEOQ/GECOP.Durante el mismo se presentaron temas de gran interés y actualidad en Oncología Quirúrgica, desarrollados en forma de ponencias o mesas redondas. La calidad de los ponentes y la asistencia han sido elevadas y el nivel de satisfacción por la participación de los inscritos y el interés de los coloquios muy altos.Tras la clausura del WORKSHOP por el Presidente de la SEOQ Dr. Jacobo Cabañas y el del Comité Organizador Dr. Fernando Pereira, se hizo entrega en formato virtual por los Directores de la COQ ASISA-UAH, del Premio Cátedra de Oncología Quirúrgica ASISA-UAH y de un accesit a las dos mejores publicaciones realizadas por un grupo español durante los dos últimos años en las revistas Clinical and Translational Oncology y European Society Of Surgical Oncology, de las que es miembro la SEOQ.

Durante la conexión los directores de la COQ ASISA-UAH felicitaron a la SEOQ por el éxito del WORKSHOP y a los autores de los trabajos por la calidad de los mismos, y se expresó la intención de continuar con la convocatoria del Premio en años sucesivos , incluso ampliar en el futuro la colaboración con la SEOQ dada la similitud de objetivos. 


  • Primer premio:

  • "Laparoscopic cytorreductive surgery and hiperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry"

    Arjona Sanchez A, Aziz O, Passot G, Salti G, Esquivel J, Van der Speeten K, Piso P, Nedelcut DS, Somarriba A, Yonemura Y,Turaga K, Selvasekar CR, Rodriguez Ortiz, L, Sanchez Hidalgo JM, Casado Adam A, Rufian Peña S, Briceño J y Glehen O. 

    Eur J Surg Oncol, 2020 (Diciembre),7983 (20)

    • ABSTRACT

    Introduction: A laparoscopic approach for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (L-CRS+HIPEC) in highly selected patients has been reported in small cohorts with a demonstrable reduction in length of stay and post-operative morbidity. This study aims to analyse individual patient data from these international centres collected through the Peritoneal Surface Oncology Group International (PSOGI) L-CRS+HIPEC registry.

    Methods: An international registry was designed through a networking database (REDCAP®). All centres performing L-CRS+HIPEC were invited through PSOGI to submit data on their cases. Patient's characteristics, postoperative outcomes and survival were analysed.

    Results: Ten international centres contributed a total of 143 L-CRS+HIPEC patients during the study period. The most frequent indication was low grade pseudomyxoma peritonei in 79/143 (55%). Other indications were benign multicyst mesothelioma in 21/143(14%) and peritoneal metastasis from colon carcinoma in 18/143 (12,5%) and ovarian carcinoma in 13/143 (9%). The median PCI was 3 (2-5). The median length of stay was 6 (5-10) days, with 30-day major morbidity rate of 8.3% and 30-day mortality rate of 0.7%. At a median follow-up of 37 (16-64) months 126/143 patients (88.2%) were free of disease.

    Conclusions: Analysis of these data demonstrates that L-CRS+HIPEC is a safe and feasible procedure in highly selected patients with limited peritoneal disease when performed at experienced centres. While short to midterm outcomes are encouraging in patients with less invasive histology, longer follow up is required before recommending it for patients with more aggressive cancers with peritoneal dissemination.


  • Accésit:

  • "Spanish multicenter study of surgical resection of pancreatic tumors infiltrating the celiac axis: does the type of pancreatectomy affect ressults?"

    Ramia JM, de Vicente E, Pardo F,Sabater L, Lopez Ben S, Quijano Y, Villegas T, Blanco Fernandez G,Diez Valladadares L, López Rojo I, Martinez Pérez E, Pereira F, Gonzalez AJ, Herrera J, García Domingo MI y Serradilla M.

    Clin Trans Oncol, 2021 Feb; 23 (2):318-324

    • ABSTRACT

    Background: Pancreatectomy plus celiac axis resection (CAR) is performed in patients with locally advanced pancreatic cancer. The morbidity rates are high, and no survival benefit has been confirmed. It is not known at present whether it is the type of pancreatectomy, or CAR itself, that is the reason for the high complication rates.

    Methods: Observational retrospective multicenter study.

    Inclusion criteria: patient undergoing TP, PD or DP plus CAR for a pancreatic cancer.

    Results: Sixty-two patients who had undergone pancreatic cancer surgery (PD,TP or DP) plus CAR were studied. Group 1: 17 patients who underwent PD/TP-CAR (13TP/4PD); group 2: 45 patients who underwent DP-CAR. Groups were mostly homogeneous. Operating time was longer in the PD/TP group, while operative complications did not differ statistically in the two groups. The number of lymph nodes removed was higher in the PD/TP group (26.5 vs 17.3), and this group also had a higher positive node ratio (17.9% vs 7.6%). There were no statistical differences in total or disease-free survival between the two groups.

    Conclusion: It seems that CAR, and not the type of pancreatectomy, influences morbidity and mortality in this type of surgery. International multicenter studies with larger numbers of patients are now needed to validate the data presented here.

    Keywords: Arterial; Cancer; DP-CAR; Distal pancreatectomy; Embolization; PHAE; Pancreas; Pancreatoduodenectomy; Review; Surgery; Total pancreatectomy.





    DIFUSIÓN DE LA NOTICIA EN EUROPA PRESS, recorte de prensa


    Un estudio internacional liderado por cirujanos del Reina Sofía de Córdoba, mejor artículo publicado en 2020

    CÓRDOBA, 21 Jun. (EUROPA PRESS) 


    Un estudio internacional liderado por cirujanos del Reina Sofía de Córdoba, mejor artículo publicado en 2020

    Un estudio internacional liderado por cirujanos el Hospital Universitario Reina Sofía de Córdoba acaba de recibir el premio al mejor artículo publicado en 2020 en Cirugía Oncológica por la Cátedra de Oncología Quirúrgica de Alcalá de Henares y la Sociedad Española de Oncología Quirúrgica.


    Leer más: https://www.europapress.es/esandalucia/cordoba/noticia-estudio-internacional-liderado-cirujanos-reina-sofia-cordoba-mejor-articulo-publicado-2020-20210621125101.html